Hi [[ session.user.profile.firstName ]]

Advanced Models for 3D Cancer Applications

In recent years, three-dimensional (3D) cell culture models have been emerging as the preferred in vitro cancer model as they better mimic the in vivo tumor microenvironment. For instance, 3D cultures develop hypoxic cores and demonstrate gradients of soluble factors and a diffusion profile for drugs similar to solid tumors. Understanding the interactions between cancer cells and other cell types in the tumor microenvironment is also critical to predicting therapeutic efficacy.

In this webinar, Audrey Bergeron will review:
•An introduction to 3D cell culture
•Assay techniques in spheroid microplates
•Several 3D cancer models and technology tools used to better capture the complexity of the tumor microenvironment in assay-compatible formats.

About the Presenter:
Audrey Bergeron is an applications scientist for Corning Life Sciences. She evaluates new products and develops protocols and technical documents using Corning cell culture products. She also provides product training to Corning employees and customers, and assists technical services with customer support by helping to troubleshoot customer experiments.
Recorded May 22 2019 23 mins
Your place is confirmed,
we'll send you email reminders
Presented by
Audrey Bergeron, Applications Scientist
Presentation preview: Advanced Models for 3D Cancer Applications

Network with like-minded attendees

  • [[ session.user.profile.displayName ]]
    Add a photo
    • [[ session.user.profile.displayName ]]
    • [[ session.user.profile.jobTitle ]]
    • [[ session.user.profile.companyName ]]
    • [[ userProfileTemplateHelper.getLocation(session.user.profile) ]]
  • [[ card.displayName ]]
    • [[ card.displayName ]]
    • [[ card.jobTitle ]]
    • [[ card.companyName ]]
    • [[ userProfileTemplateHelper.getLocation(card) ]]
  • Channel
  • Channel profile
  • マイクロキャリアを用いた幹細胞増殖およびウイルスベクター産生の培養事例の紹介 Nov 17 2020 6:00 am UTC 60 mins
    コーニングインターナショナル株式会社  ライフサイエンス事業部 石渡 孝至
    細胞治療用細胞やベクター産生の産業応用への期待が高まるにつれ、生存細胞を最大効率で回収することが求められています。そこでシングルユース製品のマイクロキャリアに ついて細胞培養事例を含めて概説します。
  • 間葉系幹細胞から血小板製造:再生医療等製品のトランスレーショナルリサーチ Oct 14 2020 6:00 am UTC 90 mins
    慶應義塾大学医学部臨床研究推進センター    特任准教授 松原 由美子 先生
    血小板は輸血や組織修復で医療応用されていますが、ドナー依存等の問題があります。私たちは基礎研究成果に基づいて、ドナーに依存しない血小板を間葉系幹細胞から遺伝子導入を必要としないシンプルな製造システムで得られる再生医療等製品の開発を行っており、その概要をご紹介いたします。
  • Maximizing Cell Yields Using Perfusion Oct 1 2020 4:00 pm UTC 60 mins
    Dr. Ann Rossi Bilodeau
    As cell therapy trials advance from pre-clinical research to late-stage trials, cell culture platforms will need to meet increasing demands for cell yield. The Corning® CellCube® system provides a simple, compact, and scalable method for mass culture of attachment-dependent cells. In this webinar, we present data supporting expansion of two commonly used bioproduction cell lines – HEK293T and Vero. The basic closed system was configured with a peristaltic pump to drive continuous circulation through the CellCube 100-layer module and paired with the Eppendorf BioFlo® 120 controller with a BioBLU® 3c single-use bioreactor for medium conditioning. The controller simplified oxygenation and pH control of the circulating medium. Medium conditioning in the SUB was sufficient to sustain both HEK293T and Vero cell growth in the CellCube 100-layer module for 5- and 6-day expansions, respectively. Final harvest yields for both HEK293T and Vero cell lines greater than 10 billion cells demonstrate the utility of the CellCube system for mass culture of adherent cell lines with efficient medium usage.

    About the Presenter:
    Dr. Ann Rossi Bilodeau graduated from the University of Rochester School of Medicine and Dentistry with a Ph.D. in Pharmacology and received postdoctoral training at the University of Chicago. Ann began her career with Corning Life Sciences as the Applications Lab Manager where she utilized her strong academic and industry research experience to direct the activities of the Applications Laboratory. Currently, Dr. Rossi Bilodeau is the Senior Bioprocess Applications Scientist, functioning as the technical lead for generating applications in support of Corning Life Sciences’ Bioprocess and Cell/Gene Therapy portfolios including CellCube and HYPERStack platforms.
  • Bacteriological Analysis of Water Sep 30 2020 1:00 pm UTC 45 mins
    Mourad Ferhat,Ph.D.
    Waterborne diseases are a leading cause of death and a global concern. Bacteriological analysis of water is one of the 3 parameters when assessing water safety. With the COVID 19 pandemic, bacteriological monitoring of water quality has become crucial for safely re-opening academia and industry. It also opens new possibilities such as the use of bacteriological analysis to detect early signs of a future outbreak.

    In this webinar you will learn:
    - Critical parameters for controlling water quality
    - Bacteriological analysis techniques and standard methods for bacterial enumeration
    - Legionella risk and how to control it
    - Tips for proper water sample collection, handling, and identification
    - Corning solutions for water sampling, testing, and analysis


    Speaker Bio:
    Mourad Ferhat, Ph.D.,
    After receiving a License in Genetics and a Master’s degree in molecular and cellular biology applied to oncology, Mourad received his Ph.D. from the University of Lyon in 2006, where he studied host-pathogen interactions to discover new mechanisms involved in the phenotypic switch of human pathogen Legionella pneumophila. After many years of experience in industry, mainly with diagnostic and life sciences companies, he joined Corning in 2019 as Product Manager for the Microbiology and Liquid Handling portfolio in EMEA.
  • Epithelial Barrier Homeostasis and Response to Infections Sep 29 2020 2:00 pm UTC 60 mins
    Dr. Francesco Boccellato
    The forefront of the gastrointestinal mucosa consists mainly of a continuous polarized epithelial monolayer protected by mucus. This strong defense barrier can be colonized by pathogens arousing a chronic inflammatory state. This exceptional colonization ability is associated with an increased risk of developing adenocarcinomas at the sites of infection. We have regenerated functional epithelial monolayers in vitro. These mucosoid cultures are human multi-lineage stem cell-based in vitro-equivalent of a real mucosa. They mimic the function of a homeostatic epithelial barrier including accumulation of mucus on the apical side. Use of human mucosoid cultures reveals novel insight into epithelial homeostasis and response to bacterial infection.

    About the presenter:
    Dr. Francesco Boccellato studied at Sapienza University of Rome. Ever since he was a student, he's been interested in the impact of pathogens in causing cancer in humans. During his Ph.D. in Rome, he studied the role of the Epstein - Barr virus (EBV) in deregulating microRNAs in diffuse large B cell lymphomas. After his Ph.D., Francesco moved to Berlin to the Max Planck Institute for Infection Biology, were he became interested in the causality of bacterial infection in human cancers. To study the impact of infection on healthy epithelial barriers Francesco invented a new cultivation systems for healthy epithelial cells called the mucosoids. The mucosoids are monolayers of polarised epithelial cells that recapitulate all the functions of an epithelial barrier in the body, including mucus production. Francesco recently started his independent group in the University of Oxford (UK) at the Ludwig Institute for Cancer Research.
  • 3D Cell Cultures and Tissue Clearing Sep 24 2020 4:00 pm UTC 60 mins
    Ian MacCloud, Laboratory Manager at Visikol Inc. and Dr. Ann Rossi Bilodeau, Corning Life Sciences
    There are many important considerations for how best to image a 3D cell culture model. Moreover, there are numerous high content imaging systems available. This webinar will review some of the systems available,best practices when imaging 3D cell culture models, and how to employ tissue clearing for improved imaging. Additionally, the presenters will share several case studies in which tissue clearing and high content confocal microscopy are integral to addressing specific research questions:
    • LED vs. laser illumination
    • Dipping vs. air objectives
    • Basic principles of confocal microscopy
    • Best practices for labeling 3D cell culture models
    • Wide field vs. confocal imaging
    • 3D image analysis

    Speaker Bio:
    Ian MacCloud is the Laboratory Manager at Visikol and a Rutgers University alumni with a background in molecular biology. Ian's research background has primarily focused on the fields of biofuels, analytic chemistry, pharmaceutical engineering, 3D cell culture models, and histology. Ian has experience in both pure research environments such as at Robert Wood Johnson (formerly UMDNJ), as well as commercial R&D labs such as the labs of The Rutgers EcoComplex and the Medical Cannabis Research Foundation. Ian has worked with multiple life science startup companies where he has found a passion for commercializing the insights gleaned from basic research in the biological sciences.

    Dr. Ann Rossi Bilodeau graduated from the University of Rochester School of Medicine and Dentistry with a Ph.D. in Pharmacology and received postdoctoral training at the University of Chicago. Currently, Dr. Rossi Bilodeau is the Senior Bioprocess Applications Scientist, functioning as the technical lead for generating applications in support of Corning Life Sciences’ Bioprocess and Cell/Gene Therapy portfolios including CellCube and HYPERStack platforms.
  • Qualidade e Acreditação em Laboratorios - Uma abordagem da influência do vidro Recorded: Sep 17 2020 76 mins
    Jerónimo Figueiredo
    Qualidade e Acreditação em Laboratorios - Uma abordagem da influência da vidraria
    Jerónimo Figueiredo - Business Operations Manager
  • HUB Organoids™: Impacting Clinical Outcomes Using Organoid Disease Models Recorded: Sep 17 2020 45 mins
    Jasper Mullenders, Ph.D.
    Key to the development of the HUB Organoid Technology was the discovery of LGR5+ intestinal adult stem cells by the Clevers’ lab. When provided with the appropriate growth factors, HUB Organoids™ proved to be both genetically and phenotypically stable during prolonged periods of cell culture and are amenable to all standard experimental manipulations, including middle through-put drug screen.

    HUB has developed a comprehensive HUB Organoid biobank from the monogenetic disease Cystic Fibrosis (CF) capturing both common and rare CFTR mutations. Similarly, HUB has created an extensive organoid biobank of different tissue origin like colon, lung, breast, pancreas, and ovary. These organoid biobanks have been characterized at the genetic and transcriptional level. They provide a unique in vitro system for screening the efficacy of both approved drugs and compounds in preclinical development. Furthermore, HUB Organoids can serve as a patient avatar in clinical development and/or diagnostics. In this setting, HUB Organoids are subjected to different treatment options and used to predict the optimal treatment for the patient. This personal medicine approach is currently under evaluation for both CF and oncology applications with the ultimate goal to improve the quality of patients’ life.
  • Segurança e Qualidade em Laboratórios - Impacto da vidraria Recorded: Sep 16 2020 91 mins
    Jerónimo Figueiredo - Business Operations Manager
    Segurança e Qualidade em Laboratórios - Impacto da vidraria
    Jerónimo Figueiredo - Business Operations Manager
  • Organogenesis to Oncogenesis Recorded: Sep 15 2020 46 mins
    Dr. Joseph Regan
    Organogenesis to Oncogenesis: Modeling Development and Cancer with Organoids
    Organoid cell culture allows mammalian stem cells to differentiate and self-organize into three-dimensional organ-like tissues that reflect the key structural and functional properties of the organs from which they are derived. In addition, organoids can be grown from patient-derived healthy and tumor tissue to provide genetically and phenotypically stable personalized preclinical models. Organoid technologies therefore provide a unique in vitro system in which to study human organ development and cancer.

    In this webinar, Dr. Regan will discuss the use of organoid technologies to study organogenesis and cell fate determination in the postnatal mammary gland. In addition, the use of patient-derived organoids (PDOs) to elucidate the molecular mechanisms that regulate oncogenesis and contribute to tumor heterogeneity in colon cancer will be discussed.

    Presenter:
    Dr. Joseph Regan graduated from The Institute of Cancer Research (University of London, UK) with a Ph.D. in Cell Biology and received postdoctoral training at the Breast Cancer Now Research Centre (London, UK) and the Max Planck Institute for Molecular Genetics (Berlin, Germany). Dr. Regan subsequently worked as a Research Scientist with Bayer AG and the Charité Medical University (Berlin, Germany), where he uses patient-derived organoid models to study cancer stem cells and tumor heterogeneity in colon cancer.
  • 最新バイオロジクス技術を用いた細胞・遺伝子治療開発の海外導入事例を紹介 Recorded: Sep 8 2020 60 mins
    コーニングインターナショナル株式会社  ライサイエンス事業部 石渡 孝至
    欧米を中心に実用化が加速し始めた細胞・遺伝子治療分野の幹細胞やウイルスベクターの産業化に向け、コーニング独自のハイパーテクノロジー(HYPERFlask®、HYPERStack®)を中心にクローズドシステムによる無菌操作法や最終製剤化の安全操作性について概説いたします。
  • Generando un Microambiente Óptimo en Todas las Etapas del Cultivo Celular Recorded: Aug 28 2020 26 mins
    Constanza Curotto
    Corning y Aplicaciones en Bioprocesos: Medio de Cultivo y Suero - Parte 3/3

    El medio de cultivo y suero son componentes esenciales del cultivo celular – suministrando nutrientes y factores claves para las células – en ese sentido, seleccionar los productos óptimos es esencial.
    En este Webinar presentaremos una revisión general del porfolio de medio y suero de Corning, y como estos productos pueden ser usados en aplicaciones de bioprocesos para realzar tanto procesos de producción e investigación.
    El portfolio de Corning incluye:
    -Diversas formulaciones de medio estándar para requerimientos específicos
    -Medio libre de suero y medios especializados
    -Suero estándar y premium
    -Selección de suero especializado.

    Biografía del Expositor
    Luego de graduarse como Bioquímico de la Universidad de Santiago de Chile, Constanza prosiguió su carrera en la industria farmacéutica veterinaria, desempeñándose como Científico de Bioprocesos tanto para el desarrollo de vacunas bacterianas y virales, estando a cargo de los procesos de escalado y generación de antígenos. Luego continuo su carrera en Bélgica, esta vez en el área de la producción de anticuerpos y proteínas recombinantes en sistemas celulares en suspensión, generando optimización de protocolos y experimentos de escalado.
  • Multiplica Tus Células, No Tu Trabajo: Cómo Escalar Cultivos en Suspensión Recorded: Aug 27 2020 28 mins
    Constanza Curotto
    Corning y Aplicaciones en Bioprocesos: Células en Suspensión - Parte 2/3

    Los procesos en suspensión juegan un rol clave en el mercado de biofarmacéuticos, donde sistemas celulares en suspensión son usados para producir anticuerpos y proteínas recombinantes. En este contexto, la selección de las plataformas de cultivo adecuadas favorece el uso eficiente del espacio, reduce costos y horas de trabajo. En este Webinar haremos una revisión general del portfolio de Corning para el cultivo en suspensión, aplicado tanto al ámbito de la investigación y desarrollo y producción. Apoyado además con datos experimentales generados por nuestros equipos de desarrollo.

    Biografía del Expositor
    Luego de graduarse como Bioquímico de la Universidad de Santiago de Chile, Constanza prosiguió su carrera en la industria farmacéutica veterinaria, desempeñándose como Científico de Bioprocesos tanto para el desarrollo de vacunas bacterianas y virales, estando a cargo de los procesos de escalado y generación de antígenos. Luego continuo su carrera en Bélgica, esta vez en el área de la producción de anticuerpos y proteínas recombinantes en sistemas celulares en suspensión, generando optimización de protocolos y experimentos de escalado.
  • Corning HYPER Technologies: Compact Solutions for Cell Scale-Up [ENG. VERSION] Recorded: Aug 27 2020 35 mins
    Dr. Lindsey Parker
    Efficient cell scale-up is essential in biologics and vaccine production to facilitate optimal product yields, whilst reducing footprint and manhours, Corning introduces the HYPER vessel technology. Corning HYPERFlasks and HYPERStacks are multilayer vessels incorporating proprietary gas-permeable film technology, resulting in high surface area to volume ratio. Using HYPER vessels, scientists can generate greater yields than traditional cell culture technologies, saving time, space and labor.

    In this webinar we will provide a general introduction of the HYPER technology, as well as technical applications in the fields of cell and gene therapy and viral particle production.

    About presenters:

    Dr. Lindsey Parker
    Lindsey completed her Ph.D. in Tissue Engineering and Regenerative Medicine at the University of Leeds (UK), validating a bioreactor for the application of mechanical stimuli to MSC. She subsequently joined UCL as an industrial KTP associate, leading clinical research in umbilical cord- derived MSC scale-up in collaboration with a tissue bank. Lindsey is currently a Bioprocess Sales Specialist at Corning, providing specialist support in bioprocess ranges, such as advising on product selection, custom products, and providing training.
  • Corning HYPER Technologies: Compact Solutions for Cell Scale-Up [SP. VERSION] Recorded: Aug 27 2020 28 mins
    Constanza Curotto
    Efficient cell scale-up is essential in biologics and vaccine production to facilitate optimal product yields, whilst reducing footprint and manhours, Corning introduces the HYPER vessel technology. Corning HYPERFlasks and HYPERStacks are multilayer vessels incorporating proprietary gas-permeable film technology, resulting in high surface area to volume ratio. Using HYPER vessels, scientists can generate greater yields than traditional cell culture technologies, saving time, space and labor.

    In this webinar we will provide a general introduction of the HYPER technology, as well as technical applications in the fields of cell and gene therapy and viral particle production.
    About presenter:

    Constanza Curotto
    After graduating from Biochemistry in the University of Santiago (Chile), Constanza pursued directly a career in the Chilean Vaccine R&D industry, developing as a bioprocess scientist for both bacterial and viral vaccines in the field of animal health, being in charge of scale-up, and tech transfer with manufacturing plants. She furthered developed her career in Belgium as a bioprocess scientist, this time in the field of recombinant protein production, pursuing protocol optimization and scale-up experiments with suspension mammalian cell lines. Constanza is currently a field applications scientist in Corning for the EMEA region, providing customers with in-depth technical support, presenting seminars and trainings, and assisting customers in experimental set-up and troubleshooting.
  • Corning HYPER Technologies: Compact Solutions for Cell Scale-Up [FR. VERSION] Recorded: Aug 27 2020 48 mins
    Dr. Sonia Meconi
    Efficient cell scale-up is essential in biologics and vaccine production to facilitate optimal product yields, whilst reducing footprint and manhours, Corning introduces the HYPER vessel technology. Corning HYPERFlasks and HYPERStacks are multilayer vessels incorporating proprietary gas-permeable film technology, resulting in high surface area to volume ratio. Using HYPER vessels, scientists can generate greater yields than traditional cell culture technologies, saving time, space and labor.

    In this webinar we will provide a general introduction of the HYPER technology, as well as technical applications in the fields of cell and gene therapy and viral particle production.

    About presenters:

    Dr. Sonia Meconi
    Sonia’s scientific background covers different fields such as biochemistry, cell biology, and immunology where she obtained a Ph.D., specifically in human infectious diseases working on a daily basis in a biologic level 3 lab. After a post-doctoral fellow and lecturer experience, she took over the head of the R&D and production teams in a small biotech which developed human serological diagnosis assays for infectious and autoimmune diseases. She oversaw pathogens (bacteria and virus) expansion supervision for protein microarray tests. Then, she joined an international company as an Application Specialist for cell culture and purification, creating new cell culture media dedicated to vaccines and cell therapy markets. Now, she joined Corning as Bioprocess Specialist working for different suppliers for the biopharmaceutical industry.
  • Corning HYPER Technologies: Compact Solutions for Cell Scale-Up [GER. VERSION] Recorded: Aug 27 2020 35 mins
    Dr. Franziska Wienholz
    Efficient cell scale-up is essential in biologics and vaccine production to facilitate optimal product yields, whilst reducing footprint and manhours, Corning introduces the HYPER vessel technology. Corning HYPERFlasks and HYPERStacks are multilayer vessels incorporating proprietary gas-permeable film technology, resulting in high surface area to volume ratio. Using HYPER vessels, scientists can generate greater yields than traditional cell culture technologies, saving time, space and labor.

    In this webinar we will provide a general introduction of the HYPER technology, as well as technical applications in the fields of cell and gene therapy and viral particle production.

    About Presenter:

    Dr. Franziska Wienholz
    Franziska completed her Ph.D. in Molecular Genetics at the Erasmus MC,The Netherlands, focusing on studying DNA repair and related diseases. During her research, she acquired extensive knowledge on cell culture and patient-derived materials, molecular techniques, and genome editing.
  • Multiplica Tus Células, No Tu Trabajo: Cómo Escalar Cultivos Adherentes Recorded: Aug 26 2020 30 mins
    Constanza Curotto
    Corning y Aplicaciones en Bioprocesos: Células Adherentes - Parte1/3

    Un escalado eficiente es esencial en la producción de fármacos biológicos; el tipo celular, aplicación y espacio dictan cual es la plataforma más adecuada para cada proceso. En este Webinar haremos una revisión general de las plataformas de cultivo de Corning para células adherentes, y como estos pueden ser empleados para el escalado en aplicaciones de bioproduccion tales como producción de vacunas, terapias celulares y producción de vectores virales.

    Biografía del Expositor:
    Luego de graduarse como Bioquímico de la Universidad de Santiago de Chile, Constanza prosiguió su carrera en la industria farmacéutica veterinaria, desempeñándose como Científico de Bioprocesos tanto para el desarrollo de vacunas bacterianas y virales, estando a cargo de los procesos de escalado y generación de antígenos. Luego continuo su carrera en Bélgica, esta vez en el área de la producción de anticuerpos y proteínas recombinantes en sistemas celulares en suspensión, generando optimización de protocolos y experimentos de escalado.
  • Harnessing the Power of 3D Spheroids in Cancer Research Recorded: Aug 25 2020 60 mins
    Roxana Ghadessy, Ph.D. and Fiona Chang, Ph.D.
    In this joint webinar, Corning and Promega will present tools and solutions to support the continuous evolution of the spheroid model in 3D cell culture applications. Learn about how culture platforms optimized for single spheroid analysis or mass spheroid production can be coupled with novel real-time cell health assays and total RNA purification techniques. Furthermore, learn how to expand the spheroid workflow with downstream analysis of miRNA effects in cancer cell growth and metastasis.

    1. Turning the volume up on spheroid production with Corning Elplasia™ microplates - Roxana Ghadessy, Ph.D.

    Roxana is a Technical Marketing Manager for Corning Life Sciences, based in Singapore. In this role she is responsible for product awareness and education activities to highlight Corning’s workflow solutions in Cell Culture, Drug Discovery and other differentiated applications. Roxana has held previous roles in Sales and Product Management at Corning, BD Biosciences and Tocris. She received her Ph.D. degree in Pharmacology from the University of Bristol.

    2. A Complete Workflow for MicroRNA Analysis Paired with Novel Cell Health Assays for 3D Cultures - Fiona Chang, Ph.D.

    Fiona is an Applications Scientist at Promega Corporation, based in Singapore. She facilitates adoption of products by performing demonstrations, troubleshooting experiments, and giving trainings. Prior to joining Promega, Fiona received her Ph.D. in Biochemistry and Molecular Biology from Monash University, Melbourne. She has been working as a research fellow at the National University of Singapore before joining the Scientific Applications Group in 2018. Fiona has since been involved in applications in the Genomics, Genetic Identity, Applied Markets, Clinical Diagnostics and Cellular Analysis product areas.
  • Seguridad y Calidad en Laboratorios - Impacto en la cristalería Recorded: Aug 19 2020 90 mins
    Jerónimo Figueiredo - Business Operations Manager
    Seguridad y Calidad en Laboratorios - Impacto en la cristalería
    Jerónimo Figueiredo - Business Operations Manager
Training for Life Science Researchers
The Corning Scientific Seminar Series is a series of free, online technical presentations that provide novel tips, best practices and proven techniques to help advance your research. Delivered by scientists to scientists, these one-hour broadcasts offer useful information and tips for lab technicians and researchers.

Embed in website or blog

Successfully added emails: 0
Remove all
  • Title: Advanced Models for 3D Cancer Applications
  • Live at: May 22 2019 4:00 pm
  • Presented by: Audrey Bergeron, Applications Scientist
  • From:
Your email has been sent.
or close